Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on May 1, 2003

Stroke. 2003
Published online before print May 1, 2003, doi: 10.1161/01.STR.0000070841.31224.29
A more recent version of this article appeared on June 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/6/1526    most recent
01.STR.0000070841.31224.29v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zausinger, S.
Right arrow Articles by Schmid-Elsaesser, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zausinger, S.
Right arrow Articles by Schmid-Elsaesser, R.
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Other Stroke Treatment - Medical
Right arrow Aneurysm, AVM, hematoma

Submitted on December 4, 2002
Accepted on December 11, 2002

Neuroprotection in Transient Focal Cerebral Ischemia by Combination Drug Therapy and Mild Hypothermia. Comparison With Customary Therapeutic Regimen

Stefan Zausinger MD*; Thomas Westermaier MD; Nikolaus Plesnila MD; Hans-Jakob Steiger MD, PhD; and Robert Schmid-Elsaesser MD, PhD

From the Department of Neurosurgery (S.Z., T.W., H-J.S., R.S-E.) and Institute for Surgical Research (N.P.), Ludwig-Maximilians University, Klinikum Grosshadern, Munich, Germany.

* To whom correspondence should be addressed. E-mail: Stefan.Zausinger{at}nc.med.uni-muenchen.de.

Background and Purpose--A combined therapeutic approach has been advocated repeatedly for treatment of focal cerebral ischemia. A clinical example of combined therapy is administration of nimodipine, mannitol, dexamethasone, and barbiturates during temporary occlusion of a cerebral artery in neurovascular surgery. We have recently demonstrated outstanding neuroprotective properties of a combination therapy with magnesium (calcium antagonist and glutamate antagonist), tirilazad (antioxidant), and mild hypothermia (MTH). In this study we compared this treatment strategy with the customary treatment options in a rat model of transient focal cerebral ischemia.

Methods--Sprague-Dawley rats (n=120) were subjected to 90 minutes of middle cerebral artery occlusion by an intraluminal filament (n=10 per group). In experiment 1, the customary treatment options (nimodipine, mannitol, dexamethasone, methohexital) were evaluated as monotherapy and in combination. In experiment 2, the customary and the new combination therapy (MTH) were compared. Mild hypothermia (33°C) was maintained for 2 hours. Neurological examinations were performed daily. Infarct size was assessed histologically after 7 days.

Results--In experiment 1, infarct volume was attenuated by 34% at maximum, with mannitol and methohexital being the most effective drugs given as monotherapy. In experiment 2, combined administration of the customary treatment options had no additive effect (infarct volume -36%). Combination therapy with MTH reduced total infarction by 73% and almost completely abolished cortical infarction (-91%). None of the animals of this group had any residual neurological deficit at the end of the observation period (P<0.05 versus all other groups).

Conclusions--The efficacy of drugs (monotherapy or in combination) most commonly used for neuroprotection during neurovascular surgery is limited. The newly proposed combination therapy (magnesium, tirilazad, and mild hypothermia), which is based on pathophysiological considerations, seems to be a promising alternative for neuroprotection in cerebrovascular surgery.


Key words: cerebral ischemia, focal • drug therapy, combination • hypothermia • laser-Doppler flowmetry • neuroprotection




This article has been cited by other articles:


Home page
Hum ReprodHome page
M.M. Binda and P.R. Koninckx
Prevention of adhesion formation in a laparoscopic mouse model should combine local treatment with peritoneal cavity conditioning
Hum. Reprod., June 1, 2009; 24(6): 1473 - 1479.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Sena, P. Wheble, P. Sandercock, and M. Macleod
Systematic Review and Meta-Analysis of the Efficacy of Tirilazad in Experimental Stroke
Stroke, February 1, 2007; 38(2): 388 - 394.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Macchiarini, H. Kamiya, C. Hagl, M. Winterhalter, J. Barbera, M. Karck, J. Pomar, and A. Haverich
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: is deep hypothermia required?
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 237 - 241.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
G. M. Tong and R. K. Rude
Magnesium Deficiency in Critical Illness
J Intensive Care Med, January 1, 2005; 20(1): 3 - 17.
[Abstract] [PDF]


Home page
StrokeHome page
Y. Liu, J. D. Barks, G. Xu, and F. S. Silverstein
Topiramate Extends the Therapeutic Window for Hypothermia-Mediated Neuroprotection After Stroke in Neonatal Rats
Stroke, June 1, 2004; 35(6): 1460 - 1465.
[Abstract] [Full Text] [PDF]